Pavurutamab Antibody
Pavurutamab (AMG-701) is an Fc-engineered, extended half-life bispecific antibody targeting CD3 and BCMA. It is designed to redirect T-cell cytotoxicity against BCMA-expressing multiple myeloma cells, with its mechanism and efficacy being investigated in preclinical in vitro and in vivo studies.
Product Specifications
Target
Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
